1990
DOI: 10.1128/mcb.10.2.830
|View full text |Cite
|
Sign up to set email alerts
|

A glycoprotein in the plasma membrane matrix as a major potential substrate of p60v-src.

Abstract: A potential substrate of p60v-src in Rous sarcoma virus-transformed cells was found to be a 130-kilodalton (kDa) glycoprotein which binds to lectin-Sepharose and can be immunoprecipitated by an anti-phosphotyrosine antibody. This glycoprotein was shown to be distinct from the fibronectin receptor and a cellular protein phosphorylated in p60v-src immune complexes. The protein was a transmembrane protein localized in the plasma membrane and resistant to extraction with Triton X-100. The 130-kDa protein was also … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
12
0

Year Published

1992
1992
2000
2000

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 49 publications
1
12
0
Order By: Relevance
“…Myristoylation of the deregulated pp60( is required to elicit all of the effects that we see in injected oocytes. Our findings support the hypothesis that phosphorylation of a substrate of pp60c`at or near the plasma membrane is involved with morphological changes associated with transformation (34,59). Our findings additionally suggest that the availability of potential substrates for pp60'S is regulated during the cell cycle.…”
supporting
confidence: 78%
“…Myristoylation of the deregulated pp60( is required to elicit all of the effects that we see in injected oocytes. Our findings support the hypothesis that phosphorylation of a substrate of pp60c`at or near the plasma membrane is involved with morphological changes associated with transformation (34,59). Our findings additionally suggest that the availability of potential substrates for pp60'S is regulated during the cell cycle.…”
supporting
confidence: 78%
“…It was somewhat unexpected, however, that our antibodies detected only a trace of SHPS-1 protein in SR3Y1 compared to that of 3Y1 (Figure 1c). To exclude the inhibitory e ect of tyrosine phosphorylation of SHPS-1 on antibody binding, tyrosine phosphorylated glycoproteins puri®ed from SR3Y1 by WGA agarose (Hamaguchi et al, 1990) was dephosphorylated by potato acid phosphatase (PAP) and, subsequently, immunoblotted with anti-SHPS-1 antibodies. As shown in Figure 1d, PAP treatment did not enhance SHPS-1 detection by the antibody raised against type-c GST-SHPS-1 in SR3Y1, although tyrosine phosphorylated glycoprotein of 130 kDa (Hamaguchi et al, 1990) was dephosphorylated.…”
Section: Expression Of Shps-1 In 3y1 and Sr3y1mentioning
confidence: 99%
“…By use of mutant src genes, several cellular proteins have been described as transformation-relevant substrates of v-Src kinase. These include; b-catenin (Hamaguchi et al, 1993a); glycoproteins of 95 kDa and 130 kDa (Hamaguchi et al, 1990;Kozuma et al, 1990); connexin-43 (Crow et al, 1992;Kanemitsu et al, 1997); 120-kDa protein (Linder and Burr, 1988). Thus, mutant src genes have been utilized as an e cient tool to characterize substrate proteins.…”
Section: Introductionmentioning
confidence: 99%
“…Tyrosine phosphorylation of proteins with apparent Mr of 130-135 kD (27,40), 120 kD (53), and 95 kD (40) has recently been found to correlate with v-src-induced transformation. It was thus of interest to see whether the inhibition of transformation of the 2R cells by DFMO was associated with changes in tyrosine phosphorylation of such proteins.…”
Section: Dfmo Treatment Interferes With the In Vivo Protein ~Rosine Pmentioning
confidence: 99%